CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹3.72 Cr | ₹2.82 Cr | ₹1.96 Cr | ₹2.30 Cr | ₹1.87 Cr |
What is the latest Long Term Provisions ratio of CONCORD BIOTECH ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹3.72 Cr |
| Mar2025 | ₹2.82 Cr |
| Mar2024 | ₹1.96 Cr |
| Mar2023 | ₹2.30 Cr |
| Mar2022 | ₹1.87 Cr |
How is Long Term Provisions of CONCORD BIOTECH Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹3.72 Cr | 31.91 | |
| Mar2025 | ₹2.82 Cr | 44.17 | |
| Mar2024 | ₹1.96 Cr | -14.85 | |
| Mar2023 | ₹2.30 Cr | 22.57 | |
| Mar2022 | ₹1.87 Cr | - | |
Compare Long Term Provisions of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹13,060.9 Cr | -5.3% | -3.8% | -29.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | 1.1% | 4.6% | 14.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | 0.6% | 8.3% | 8.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | 6.3% | 12.2% | 45.5% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -1.7% | -2.8% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -3.7% | -10.4% | -6% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | -5.3% |
-3.8% |
-29.9% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses